POTENTIAL ANTIATHEROSCLEROTIC AGENTS .5. AN ACYL-COA - CHOLESTEROL O-ACYLTRANSFERASE INHIBITOR WITH HYPOCHOLESTEROLEMIC ACTIVITY

被引：48
作者：
DEVRIES, VG
SCHAFFER, SA
LARGIS, EE
DUTIA, MD
WANG, CH
BLOOM, JD
KATOCS, AS
机构：
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 1986年 / 29卷 / 07期
关键词：
D O I：
10.1021/jm00157a002
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：1131 / 1133
页数：3
相关论文
共 50 条
[31]   SUBACUTE TOXICITY OF A NOVEL INHIBITOR OF ACYL-COA - CHOLESTEROL ACYLTRANSFERASE IN BEAGLE DOGS [J].
DOMINICK, MA ;
MCGUIRE, EJ ;
REINDEL, JF ;
BOBROWSKI, WF ;
BOCAN, TMA ;
GOUGH, AW .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1993, 20 (02) :217-224
[32]   Guineensine, an Acyl-CoA:: cholesterol acyltransferase inhibitor, from the fruits of Piper longum [J].
Lee, SW ;
Rho, MC ;
Nam, JY ;
Lim, EH ;
Kwon, OE ;
Kim, YH ;
Lee, HS ;
Kim, YK .
PLANTA MEDICA, 2004, 70 (07) :678-679
[33]   TOXICOLOGIC EFFECTS OF A NOVEL ACYL-COA - CHOLESTEROL ACYLTRANSFERASE INHIBITOR IN CYNOMOLGUS MONKEYS [J].
REINDEL, JF ;
DOMINICK, MA ;
BOCAN, TMA ;
GOUGH, AW ;
MCGUIRE, EJ .
TOXICOLOGIC PATHOLOGY, 1994, 22 (05) :510-518
[34]   Compared with Acyl-CoA:cholesterol O-acyltransferase (ACAT) 1 and lecithin:cholesterol acyltransferase, ACAT2 displays the greatest capacity to differentiate cholesterol from sitosterol [J].
Temel, RE ;
Gebre, AK ;
Parks, JS ;
Rudel, LL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (48) :47594-47601
[35]   Novel hydroxyphenylurea dual inhibitor against acyl-CoA: Cholesterol acyltransferase (ACAT) and low density lipoprotein (LDL) oxidation as antiatherosclerotic agent [J].
Nakao, K ;
Kubota, H ;
Yasuhara, M ;
Saito, K ;
Suzuki, T ;
Ohmizu, H ;
Shimizu, R .
BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (04) :853-861
[36]   CHEMICAL MODIFICATION AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF PYRIPYROPENES - POTENT, BIOAVAILABLE INHIBITOR OF ACYL-COA-CHOLESTEROL O-ACYLTRANSFERASE (ACAT) [J].
OBATA, R ;
SUNAZUKA, T ;
TOMODA, H ;
HARIGAYA, Y ;
OMURA, S .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (22) :2683-2688
[37]   5,6-diphenylpyridazine derivatives as acyl-CoA:cholesterol acyltransferase inhibitors [J].
Giovannoni, MP ;
Dal Piaz, V ;
Kwon, BM ;
Kim, MK ;
Kim, YK ;
Toma, L ;
Barlocco, D ;
Bernini, F ;
Canavesi, M .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (24) :4292-4295
[38]   STIMULATION OF ACYL-COA - CHOLESTEROL ACYLTRANSFERASE ACTIVITY BY HYPERLIPEMIC SERUM-LIPOPROTEINS [J].
ROTHBLAT, GH ;
NAFTULIN, M ;
ARBOGAST, LY .
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1977, 155 (04) :501-506
[39]   INDUCTION OF INTRACELLULAR ACYL-COA - CHOLESTEROL ACYLTRANSFERASE ACTIVITY IN GLIOBLASTOMA CELLS BY LIDOCAINE [J].
JENG, IM ;
KLEMM, N ;
BRESSIE, S ;
SAMSON, L .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1985, 237 (02) :415-422
[40]   Pheophorbide a-methyl ester, acyl-coa: cholesterol acyltransferase inhibitor fromDiospyros kaki [J].
Mun-Chual Rho ;
Mi Yeon Chung ;
Hye Young Song ;
Oh Eok Kwon ;
Seung Woong Lee ;
Jin Ah Baek ;
Kyung Hee Jeune ;
Koanhoi Kim ;
Hyun Sun Lee ;
Young Kook Kim .
Archives of Pharmacal Research, 2003, 26 :716-718
12345